Balentine LLC’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,465
Closed -$1.78M 367
2024
Q1
$1.78M Buy
4,465
+1,802
+68% +$681K 0.05% 113
2023
Q4
$898K Buy
2,663
+495
+23% +$148K 0.03% 187
2023
Q3
$634K Sell
2,168
-18
-0.8% -$5.62K 0.02% 223
2023
Q2
$747K Buy
2,186
+246
+13% +$74.4K 0.02% 208
2023
Q1
$496K Buy
1,940
+10
+0.5% +$2.46K 0.02% 312
2022
Q4
$512K Buy
1,930
+106
+6% +$25.8K 0.02% 336
2022
Q3
$342K Buy
+1,824
New +$392K 0.01% 365
2020
Q3
Sell
-183
Closed -$35K 509
2020
Q2
$35K Buy
183
+105
+135% +$18.8K ﹤0.01% 285
2020
Q1
$13K Sell
78
-318
-80% -$58.2K ﹤0.01% 327
2019
Q4
$78K Buy
396
+336
+560% +$62.9K ﹤0.01% 139
2019
Q3
$11K Buy
60
+12
+25% +$2.08K ﹤0.01% 327
2019
Q2
$8K Buy
+48
New +$8.22K ﹤0.01% 364

Other funds holding ISRG

Balentine LLC's ISRG Position: Q2 2024 in Review

Balentine LLC sold out of Intuitive Surgical (ISRG) in Q2 2024, closing a stake of 4,465 shares — an estimated $1.78M sold.

Balentine LLC first reported a position in ISRG in Q2 2019 and held it in 12 quarters. The position peaked at $1.78M in Q1 2024. 1,821 funds tracked by Wall St. Rank hold ISRG as of Q2 2024.

  • Balentine LLC reported no remaining Intuitive Surgical position as of Q2 2024 after selling out during the quarter.
  • Balentine LLC sold 4,465 Intuitive Surgical shares in Q2 2024, an estimated $1.78M.
  • Balentine LLC first reported a position in Intuitive Surgical in Q2 2019 and held it in 12 quarters.
  • Balentine LLC's Intuitive Surgical position peaked at $1.78M in Q1 2024.
  • 1,821 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2024.

Based on Balentine LLC's 13F filing for Q2 2024, filed 7 Aug 2024.